Discover

OTLK
Outlook Therapeutics, Inc.
1.47
37 x 1.43
2 x 1.81
bid
ask
-
0.12
7.55%
20 @ 06:26 AM
1.47 +0.00 (0.00%)
Ytd-6.96%
1y-6.96%
1.42
day range
1.57
0.16
52 week range
3.39
Open1.55Prev Close1.59Low1.42High1.57Mkt Cap177.67M
Vol8.77MAvg Vol18.92MEPS-1.13P/EN/AForward P/E-0.55
Beta0.63Short Ratio1.26Inst. Own35.63%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg0.73200-d Avg0.901yr Est24.80
Income Statement
Total Revenue127.44K
Revenues (USD)127.44K
Cost of Revenue149.33K
Gross Profit-21.89K
Operating Expenses14.01M
Research and Development Expense4.50M
Selling, General and Administrative Expense9.50M
Operating Income-14.03M
Interest Expense-3.00
Net Income-4.45M
Net Income Common Stock-4.45M
Net Income Common Stock (USD)-4.45M
Consolidated Income-4.45M
Earnings per Basic Share-0.05
Earnings per Basic Share (USD)-0.05
Earnings per Diluted Share-0.05
Earning Before Interest & Taxes (EBIT)-4.45M
Earning Before Interest & Taxes (USD)-4.45M
Weighted Average Shares81.84M
Weighted Average Shares Diluted81.84M
Balance Sheet
Cash and Equivalents7.75M
Cash and Equivalents (USD)7.75M
Investments468.43K
Investments Non-Current468.43K
Trade and Non-Trade Receivables2.72M
Current Assets20.90M
Property, Plant & Equipment Net198.98K
Total Assets21.89M
Debt Current15.91M
Total Debt27.19M
Current Liabilities38.88M
Debt Non-Current11.28M
Total Liabilities50.89M
Accumulated Retained Earnings (Deficit)-633.22M
Shareholders Equity-28.99M
Shareholders Equity (USD)-28.99M
Assets Non-Current987.70K
Total Debt (USD)27.19M
Inventory3.34M
Liabilities Non-Current12.00M
Trade and Non-Trade Payables13.64M
Tax Liabilities302.00K
Cash Flow
Depreciation, Amortization & Accretion30.42K
Net Cash Flow from Financing6.90M
Net Cash Flow / Change in Cash & Cash Equivalents-929.20K
Issuance (Purchase) of Equity Shares6.90M
Net Cash Flow from Operations-7.83M
Share Based Compensation757.48K